Brief: Ajanta Pharma says U.S. unit launches eletriptan hydrobromide tablets
Aug 31 (Reuters) - Ajanta Pharma Ltd AJPH.NS
* Says launched eletriptan hydrobromide tablets in US market
through our wholly owned subsidiary, Ajanta Pharma USA Inc.
Source text for Eikon: ID:nBSE75P1rg
Further company coverage: AJPH.NS
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Ajanta Pharma
See all newsIndia's Ajanta Pharma falls as analysts say growth to moderate in H2
Brief: Ajanta Pharma Limited Sept-Quarter Consol Net Profit 3.88 Billion Rupees
India's Ajanta Pharma jumps on June quarter profit jump
Brief: Ajanta Pharma June-Quarter Consol PAT 3.34 Billion Rupees
Brief: Ajanta Pharma Receives US FDA Establishment Inspection Report For Paithan Facility